132 related articles for article (PubMed ID: 29901594)
1. Adult-onset renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: 3 case reports and review of literature.
Gong P; Zhuang Q; Wang K; Xu R; Chen Y; Wang X; Yin S
Medicine (Baltimore); 2018 Jun; 97(24):e11023. PubMed ID: 29901594
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic strategies and predictive models for Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma in adults based on data of two Chinese medical centers.
Yang Y; Zhao C; Wang Z; Liu F; Zhao M; Yang H; Chen J; Chen X; Shi M; Jiang D; Luo X; Duan Y; Bai Y
Aging (Albany NY); 2024 Jan; 16(2):1696-1711. PubMed ID: 38261736
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma.
Choueiri TK; Lim ZD; Hirsch MS; Tamboli P; Jonasch E; McDermott DF; Dal Cin P; Corn P; Vaishampayan U; Heng DY; Tannir NM
Cancer; 2010 Nov; 116(22):5219-25. PubMed ID: 20665500
[TBL] [Abstract][Full Text] [Related]
4. Multicystic Clear Cell Renal Tumors With Low-grade Nuclear Features: Time to Include TFE3 Translocation-associated Carcinomas.
Cai Q; Gagan J; Koduru P; Cadeddu J; Shah RB; Kapur P; Palsgrove DN
Adv Anat Pathol; 2024 Jan; 31(1):34-42. PubMed ID: 37937590
[TBL] [Abstract][Full Text] [Related]
5. Multimodality imaging of Xp11.2 translocation/TFE3 gene fusion associated with renal cell carcinoma: a case report.
Huang W; Peng Y; Zhang Y; Qiu Y; Liu Y; Wang A; Kang L
Front Med (Lausanne); 2023; 10():1266630. PubMed ID: 37795411
[TBL] [Abstract][Full Text] [Related]
6. TFE3-Splicing Factor Fusions Represent Functional Drivers and Druggable Targets in Translocation Renal Cell Carcinoma.
Damayanti NP; Cordova RA; Rupert C; Delle Fontane I; Shen L; Orsi S; Klunk AJ; Linehan WM; Staschke KA; Hollenhorst PC; Heppner DE; Pili R
Cancer Res; 2024 Apr; 84(8):1286-1302. PubMed ID: 38266162
[TBL] [Abstract][Full Text] [Related]
7. Prognosis and Clinicopathological Characters of Adult TFEB-Altered Renal Cell Carcinoma: A Single Center Experience of 18 Cases.
Wu J; Cao CZ; Cui HL; Du G; Shi HZ; Liang J; Guo L; Wang YC; Zhang J; Zhou AP; Li CL; Zheng S; Shou JZ
Clin Genitourin Cancer; 2024 Apr; 22(2):261-268.e3. PubMed ID: 38104031
[TBL] [Abstract][Full Text] [Related]
8. MiT family translocation-associated renal cell carcinoma: A report of two cases in children.
Mukherjee S; Basu K; Basu KS; Chatterjee U
Indian J Pathol Microbiol; 2024 Apr; 67(2):469-471. PubMed ID: 38391376
[TBL] [Abstract][Full Text] [Related]
9. Renal cell carcinoma associated with Xp11.2 translocation/transcription factor E3 gene fusion: A case report and literature review.
Yang D; Tang W; Liu M; Xie Z; Shi F; Zhao Z; Yang X; Wu T
Oncol Lett; 2024 Jan; 27(1):29. PubMed ID: 38073770
[TBL] [Abstract][Full Text] [Related]
10. The Transition From Localized to Metastatic: A Case Report of Adult TFE3-Positive Xp11.2 Translocation Renal Cell Carcinoma.
Naviwala MS; Dawood T; Uddin Z; Chundriger Q; Jalbani IK
Cureus; 2023 Aug; 15(8):e43378. PubMed ID: 37700986
[TBL] [Abstract][Full Text] [Related]
11. A nomogram based on TFE3 IHC results and clinical factors as a preliminary screening scheme for TFE3-rearranged renal cell carcinoma.
Li P; Xu Q; Chen M; Zhu J; Wang Y; Mumin MA; Huang K; Jiang Z; Liang H; Deng Q; Wang Z; Liao B; Chen W; Cao Y; Cao J; Luo J
Cancer Med; 2024 Mar; 13(5):e6813. PubMed ID: 38477529
[TBL] [Abstract][Full Text] [Related]
12. Recurrent YAP1-TFE3 Gene Fusions in Clear Cell Stromal Tumor of the Lung.
Agaimy A; Stoehr R; Michal M; Christopoulos P; Winter H; Zhang L; Stenzinger A; Michal M; Mechtersheimer G; Antonescu CR
Am J Surg Pathol; 2021 Nov; 45(11):1541-1549. PubMed ID: 33899786
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Renal Cell Carcinoma Harboring
Woo CG; Yun SJ; Son SM; Lim YH; Lee OJ
Yonsei Med J; 2020 Mar; 61(3):262-266. PubMed ID: 32102128
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of TFE3 in granular cell tumor: Four cases in pediatrics.
Yu L; He L
Pediatr Blood Cancer; 2024 Mar; 71(3):e30811. PubMed ID: 38073015
[No Abstract] [Full Text] [Related]
15. Metastatic Translocated Renal Cell Carcinoma in a Kidney Transplant Patient - a Case Report and Review of the Literature.
Kläger J; Schmidinger M; Oszwald A; Wasinger G; Fajkovic H; Compérat E
Int J Surg Pathol; 2024 May; 32(3):594-600. PubMed ID: 37415400
[No Abstract] [Full Text] [Related]
16. Primary renal carcinoid tumors: Three case reports.
Chen Y; Shu Y; He L; Wu K
Medicine (Baltimore); 2021 Feb; 100(8):e24714. PubMed ID: 33663082
[TBL] [Abstract][Full Text] [Related]
17. Papillary Renal Cell Carcinoma in Transplanted Kidney and Xp11.2 Translocation/Transcription Factor E3-Rearranged Renal Cell Carcinoma in the Native Kidney: A Case Report.
Kim MH; Kim KA; Kim JW; Lee SY; Choi JW
J Korean Soc Radiol; 2024 Mar; 85(2):437-444. PubMed ID: 38617860
[TBL] [Abstract][Full Text] [Related]
18. [Gallbladder metastasis of clear cell renal carcinoma].
Gasque RA; Vera AB; Mocciaro D; Díaz Pantoja JP; Moreno WA; Vigilante GE
Medicina (B Aires); 2023; 83(6):998-1002. PubMed ID: 38117722
[TBL] [Abstract][Full Text] [Related]
19. Rare ectopic metastasis from clear cell renal cell carcinoma to the chest wall after 10 years: A case report.
Jiang C; Zhao S; Yang B; Tang T; Hou R; Liu X; Zhao H
Medicine (Baltimore); 2018 May; 97(19):e0687. PubMed ID: 29742714
[TBL] [Abstract][Full Text] [Related]
20. The MRI features of renal inflammatory pseudotumor: A case report and literature review.
Han Y; Yang G; Du J; Tan Y; Zhang H
Medicine (Baltimore); 2023 Mar; 102(12):e33287. PubMed ID: 36961141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
